Deutsche Bank analyst Bryan Keane lowered the firm’s price target on Genpact to $37 from $48 and keeps a Hold rating on the shares. The company’s record bookings are offset by lower short-cycle work, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on G: